HCA Holdings, Inc. (NYSE:HCA)‘s stock had its “buy” rating restated by investment analysts at Oppenheimer Holdings, Inc. in a report issued on Thursday, October 19th. They currently have a $90.00 target price on the stock, down from their previous target price of $95.00. Oppenheimer Holdings, Inc.’s target price points to a potential upside of 17.39% from the stock’s current price. Oppenheimer Holdings also issued estimates for HCA Holdings’ Q4 2017 earnings at $1.80 EPS, Q1 2018 earnings at $1.72 EPS, Q2 2018 earnings at $1.81 EPS, Q3 2018 earnings at $1.68 EPS and Q4 2018 earnings at $2.03 EPS.
Other equities research analysts have also recently issued research reports about the stock. Argus lowered their target price on shares of HCA Holdings from $100.00 to $93.00 and set a “buy” rating on the stock in a report on Monday, August 14th. Zacks Investment Research raised shares of HCA Holdings from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a report on Thursday, July 13th. Cantor Fitzgerald reissued a “buy” rating and set a $95.00 target price on shares of HCA Holdings in a report on Wednesday, September 6th. KeyCorp restated a “buy” rating and set a $95.00 price target on shares of HCA Holdings in a research report on Thursday, September 7th. Finally, Robert W. Baird restated a “buy” rating on shares of HCA Holdings in a research report on Thursday, September 28th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and sixteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $91.25.
HCA Holdings (NYSE:HCA) traded down 0.29% during midday trading on Thursday, hitting $76.67. The stock had a trading volume of 2,899,665 shares. HCA Holdings has a 52 week low of $67.00 and a 52 week high of $91.03. The firm has a market cap of $27.70 billion, a P/E ratio of 10.28 and a beta of 0.62. The stock has a 50-day moving average of $77.78 and a 200-day moving average of $81.54.
HCA Holdings (NYSE:HCA) last issued its earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The business had revenue of $10.73 billion for the quarter, compared to the consensus estimate of $10.76 billion. During the same period in the previous year, the firm earned $1.66 EPS. The company’s revenue was up 4.0% compared to the same quarter last year. Analysts forecast that HCA Holdings will post $6.76 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “HCA Holdings, Inc. (HCA) Earns Buy Rating from Oppenheimer Holdings, Inc.” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/10/28/hca-holdings-inc-hca-rating-reiterated-by-oppenheimer-holdings-inc.html.
In other HCA Holdings news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $79.87, for a total transaction of $171,720.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Over the last 90 days, insiders have sold 6,450 shares of company stock valued at $511,163. Company insiders own 2.90% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. boosted its position in HCA Holdings by 14.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after buying an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in shares of HCA Holdings by 35.1% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after acquiring an additional 320 shares during the last quarter. Atlantic Trust LLC bought a new position in shares of HCA Holdings during the second quarter valued at about $118,000. Lee Financial Co bought a new position in shares of HCA Holdings during the second quarter valued at about $125,000. Finally, Acrospire Investment Management LLC raised its stake in shares of HCA Holdings by 14.3% during the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after acquiring an additional 200 shares during the last quarter. Institutional investors and hedge funds own 73.72% of the company’s stock.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.